Samsung is unveiling its new HS50 and HS60 ultrasound systems at the American College of Obstetricians and Gynecologists annual meeting in San Diego from May 6-9, 2017.
Background
Samsung NeuroLogica is the healthcare subsidiary of Samsung Electronics Co., Ltd. The company develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. With its new ultrasound offerings, the company says it is targeting busy clinical practices by offering a compact design with a simplified workflow. Furthermore it says the systems deliver excellent imaging performance, and advanced measurement and volume imaging capabilities that enable users to effectively manage routine exams.
With FDA clearance granted earlier this spring, the HS50 and HS60 feature hybrid beamformer technology that works in conjunction with Samsung’s advanced Digital Signal Processing to provide clear, detailed images that help clinicians confidently diagnose and care for their patients. Advanced 3D/4D technologies provide additional diagnostic views to help support clinical decision making and treatment planning. Workflow-enhancing and time-saving tools allow the clinician to focus more on their patients instead of the system. The well-rounded capabilities of the HS50 and HS60 make them applicable for many different practice types, including Obstetrics and Gynecology, General Imaging and MSK.
Company comments
“With the introduction of the HS50 and HS60, Samsung is able to bring the exceptional image quality and penetration that our high-end customers have come to expect and rely on to a wider audience,” said Phil Sullivan, President and CEO for Samsung NeuroLogica. “With its smaller footprint and affordability, it will allow more clinicians to provide their patients the very best of care.”
Source: Business Wire
published: May 8, 2017 in: Approval/Clearance, Congresses and Meetings, Gynaecology/Obstetrics, Imaging, Launches / Withdrawals